Solid-Phase Synthesis of Aryl O-Glycoside Using Aqueous Base and Phase-Transfer Catalyst

Tatsuya Zenkoh; Hiroshi Tanaka; Hiroyuki Setoi; Takashi Takahashi

doi:10.1055/s-2002-31926

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2002(6): 0867-0870
DOI: 10.1055/s-2002-31926

LETTER

Solid-Phase Synthesis of Aryl O-Glycoside Using Aqueous Base and Phase-Transfer Catalyst

Tatsuya Zenkoh^a, Hiroshi Tanaka^c, Hiroyuki Setoi^b, Takashi Takahashi*^c
^a Exploratory Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan
Fax: +81(298)478610; e-Mail: tatsuya_zenkoh@po.fujisawa.co.jp;
^b Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., 2-1-6 Kashima, Yodogawa-ku, Osaka 532-8514, Japan
^c Department of Applied Chemistry, Tokyo Institute of Technology, Ookayama, Meguro, Tokyo 152-8552, Japan
Fax: +81(3)57342884; e-Mail: thiroshi@o.cc.titech.ac.jp;

Further Information

Publication History

Received 5 March 2002
Publication Date:
07 February 2007 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

We describe an efficient solid-phase synthesis of aryl O-glycosides using aqueous base and phase-transfer catalyst. This methodology can provide aryl O-glycosides selectively in excellent yield and purity without the production of C-glycoside. Application of this methodology to the synthesis of Phlorizin type aryl O-glycosides is reported.

Key Words

solid-phase synthesis - aryl O-glycoside - phase-transfer catalyst - glycosylation - phlorizin

References and Notes

1a Dolle RE. J. Comb. Chem. 2001, 3: 477

Crossref PubMed Google Scholar
1b Hall DG. Manku S. Wang F. J. Comb. Chem. 2001, 3: 125

Crossref PubMed Google Scholar
1c Booth S. Hermkens PHH. Ottenheijm HCJ. Rees DC. Tetrahedron 1998, 54: 15385

Crossref PubMed Google Scholar
1d Cowley PM. Rees DC. Cur. Med. Chem. 1997, 4: 211

Crossref PubMed Google Scholar
1e Thompson LA. Ellman JA. Chem. Rev. 1996, 96: 555

Crossref PubMed Google Scholar
1f Fruchtel JS. Jung G. Angew. Chem., Int. Ed. Engl. 1996, 35: 17

Crossref PubMed Google Scholar
1g Gordon EM. Barrett RW. Dower WJ. Fodor SPA. Gallop MA. J. Med. Chem. 1994, 37: 1385

Crossref PubMed Google Scholar
1h Gallop MA. Barrett RW. Dower WJ. Fodor SPA. Gordon EM. J. Med. Chem. 1994, 37: 1233

Crossref PubMed Google Scholar
2a Furka A. Sebestyen F. Asgedom M. Dibo G. Abstr. 14th Int. Congr. Biochem., Prague, Czechoslovakia 1988, 5: 47

Google Scholar
2b Furka A. Sebestyen F. Asgedom M. Dibo G. Abstr. 14th Int. Symp. Med. Chem., Budapest: Hungary 1988, 288

Google Scholar
2c Nicolaou KC. Xiao X.-Y. Parandoosh Z. Senyei A. Nova MP. Angew. Chem., Int. Ed. Engl. 1995, 34: 2289

Google Scholar
3a Lou H. Li X. Onda M. Konda Y. Machida T. Toda Y. Harigaya Y. J. Nat. Prod. 1993, 56: 1437

Crossref Google Scholar
3b Aimi N. Hoshino H. Nishimura M. Sakai S. Haginiwa J. Tetrahedron Lett. 1990, 31: 5169

Crossref Google Scholar
3c Yoshikawa M. Shimada H. Nishida N. Li Y. Toguchida I. Yamahara J. Matsuda H. Chem. Pharm. Bull. 1998, 46: 113

Crossref Google Scholar
3d Calis I. Heilmann J. Tasdemir D. Linden A. Ireland CM. Sticher O. J. Nat. Prod. 2001, 64: 961

Crossref Google Scholar
3e Li X.-C. Jacob MR. Pasco DS. El Sohly HN. Nimrod AC. Walker LA. Clark AM. J. Nat. Prod. 2001, 64: 1282

Crossref Google Scholar
4a Demetzos C. Skaltsounis A.-L. Tillequin F. Koch M. Carbohydr. Res. 1990, 207: 131

Article in Thieme Connect Google Scholar
4b Kleine HP. Weinberg DV. Kaufman RJ. Sidhu RS. Carbohydr. Res. 1985, 142: 333

Article in Thieme Connect Google Scholar
4c Dess D. Kleine HP. Weinberg DV. Kaufman RJ. Synthesis 1981, 883

Article in Thieme Connect Google Scholar
5a Diedrich DF. J. Med. Pharm. Chem. 1962, 5: 1054

Google Scholar
5b Konda Y. Iwasaki Y. Takahata S. Arima S. Toida T. Kaji E. Takeda K. Harigaya Y. Chem. Pharm. Bull. 1997, 45(4): 626

Google Scholar
5c Hongu M. Saito K. Tsujihara K. Synth. Commun. 1999, 29: 2775

Google Scholar
6 Gong Y.-D. Yoo S.-E. Bull. Korean Chem. Soc. 2001, 22(9): 941

Google Scholar
8a Uozumi Y. Danjo H. Hayashi T. Tetrahedron Lett. 1997, 38: 3557

Google Scholar
8b Bayer E. Rapp W. Chemistry of Peptides and Proteins Vol. 3: Voelter W. Bayer E. Ovchinikov YA. Iwanov VT. Walter de Gruyter; Berlin: 1986. p.3

Google Scholar
8c Rapp W. In Combinatorial Peptide and Nonpeptide Libraries Jung G. VCH; Weilheim: 1996. p.425

Google Scholar
9a O’Donnell MJ. Zhou C. Scott WL. J. Am. Chem. Soc. 1996, 118: 6070

Crossref Google Scholar
9b O’Donnell MJ. Delgado F. Hostettler C. Schwesinger R. Tetrahedron Lett. 1998, 39: 8775

Crossref Google Scholar
9c O’Donnell MJ. Drew MD. Pottorf RS. Scott WL. J. Comb. Chem. 2000, 2: 172

Crossref Google Scholar
13a Review: McKee FW. Hawkins WB. Physiol. Rev. 1945, 25: 255

Google Scholar
13b Alvarado F. Crane RK. Physiol. Rev. 1964, 93: 116

Google Scholar
13c Toggenburger G. Kessler M. Semenza G. Physiol. Rev. 1982, 688: 557

Google Scholar
14 Miles CO. Main L. Nicholson BK. Aust. J. Chem. 1989, 42: 1103

Google Scholar

7

ArgoGel^Τ ^Μ (Wang chloride resin) was purchased from Argonaut Technologies, San Carlos, CA.

10

Column: Mightysil RP-18 GP (ODS) 3 µm, 4.6 mmI. D. × 50 mm; mobile phase: 20 mM NH₄OAc: MeOH = 70: 30 (0 min) Æ 10:90 (4 - 8 min); UV: 254 nm.

11

General Procedure for Glycosylation of Phenol Exemplified with the Synthesis of m -10: The resin m -6 (4 × 30 mg, 0.17 mmol/g) was loaded into IRORI^Τ ^Μ MicroKans. To a solution of Cs₂CO₃ in THF-MeOH (1:1, 4 mL) was added the MicroKans at ambient temperature. After being shaked for 17 h at the same temperature, the reaction mixture was drained to isolate the Kans. The Kans were sequentially washed with DMF (4 × 5 mL), THF-water (2:1, 4 × 5 mL), 5% HOAc-THF (4 × 5 mL), THF (4 × 5 mL), MeOH (4 × 5 mL), and dichloromethane (DCM) (4 × 5 mL) and dried in vacuo to give immobilized phenol m -7 in four Kans. Three MicroKans among them were exposed to a solution of glucosyl bromide 8a (463 mg) in 1,2-dichloroethane (4.2 mL). To the mixture were successively added 5% NaOH aq (2.1 mL), benzyl tri-n-butylammonium chloride (21.9 mg). After being shaked at ambient temperature for 15 h, the mixture was drained. Remaining three Kans were washed sequentially with DCM (5 mL), DMF (4 × 5 mL), THF-MeOH (1:1, 2 × 5 mL), 5% HOAc-THF (2 × 5 mL), THF (4 × 5 mL), MeOH (4 × 5 mL), and DCM (4 × 5 mL) and dried to give glycoside m -9. The resin in the three MicroKans was cleaved with 10% TFA-DCM (5 mL) for 30 min. The resulting solution was diluted with DCM (5 mL) and toluene (2 mL). The MicroKans were removal from the solution by means of tweezers. The acidic solution was concentrated to afford m -10 (9.8 mg, 0.014 mmol, 93%). Spectrum data of m -10: ¹H NMR (300 MHz, CDCl₃): δ = 8.03 (2 H, dd, J = 1.2, 8.4 Hz), 7.99-7.90 (4 H, m), 7.86 (2 H, dd, J = 1.5, 8.4 Hz), 7.58-7.25 (13 H, m), 7.04-6.97 (1 H, m), 6.60-6.47 (3 H, m), 5.98 (1 H, dd, J = 9.4, 9.6 Hz), 5.79 (1 H, dd, J = 7.8, 9.4 Hz), 5.70 (1 H, dd, J = 9.4, 9.6 Hz), 5.37(1 H, d, J = 7.8 Hz), 4.68 (1 H, dd, J = 3.3, 12.3 Hz), 4.53 (1 H, dd, J = 6.3, 12.3Hz), 4.37-4.28 (1 H, m); MS (ESI): 706 [M + NH₄ ⁺].

12

Spectrum data, p -10: ¹H NMR (300 MHz, CDCl₃): δ = 8.05-7.82 (8 H, m), 7.58-7.24 (13 H, m), 6.89 (2 H, d, J = 9.0 Hz), 6.61 (2 H, d, J = 9.0 Hz), 5.97 (1 H, dd, J = 9.6, 9.9 Hz), 5.76 (1 H, dd, J = 8.1, 9.9 Hz), 5.70 (1 H, dd, J = 9.6, 9.9 Hz), 5.26 (1 H, d, J = 8.1 Hz), 4.66 (1 H, dd, J = 3.0, 12.3 Hz), 4.53 (1 H, dd, J = 6.3, 12.3 Hz), 4.30-4.23 (1 H, m); MS (ESI): 706 [M + NH₄ ⁺].

15

Spectrum data, 18a: ¹H NMR (300 MHz, CDCl₃): δ = 12.99 (1 H, s), 7.99 (2 H, d, J = 8.0 Hz), 7.96-7.89 (4 H, m), 7.84 (2 H, d, J = 8.0 Hz), 7.60-7.24 (12 H, m), 7.10 (1 H, dd, J = 8.1, 8.4 Hz), 6.61 (1 H, d, J = 8.4 Hz), 6.56 (1 H, d, J = 8.1 Hz), 6.03 (1 H, dd, J = 9.6, 10.0 Hz), 5.92 (1 H, dd, J = 7.5, 9.6 Hz), 5.74 (1 H, dd, J = 9.6, 10.0 Hz), 5.63 (1 H, d, J = 7.5 Hz), 4.68 (1 H, dd, J = 2.7, 13.2 Hz), 4.52 (1 H, dd, J = 7.8, 13.2 Hz), 4.42-4.33 (1 H, m), 2.61 (3 H, s); MS (ESI): 748 [M + NH₄ ⁺]. 18b: ¹H NMR (300 MHz, CDCl₃): δ = 13.00 (1 H, s), 8.09 (2 H, dd, J = 1.5, 8.4 Hz), 8.03 (2 H, dd, J = 1.5, 8.4 Hz), 7.91 (2 H, dd, J = 1.5, 8.7 Hz), 7.81 (2 H, dd, J = 1.5, 8.7 Hz), 7.68-7.23 (12 H, m), 7.10 (1 H, dd, J = 7.5, 8.4 Hz), 6.63 (1 H, d, J = 7.5 Hz), 6.60 (1 H, d, J = 8.4 Hz), 6.17 (1 H, dd, J = 8.1, 10.2 Hz), 6.07 (1 H, d, J = 3.3 Hz), 5.71 (1 H, dd, J = 3.3, 10.2 Hz), 5.62 (1 H, d, J = 8.1 Hz), 4.67-4.50 (3 H, m), 2.65 (3 H, s); MS (ESI): 748 [M + NH₄ ⁺]. 18c: ¹H NMR (300 MHz, CDCl₃): δ = 12.97 (1 H, s), 8.03 (2 H, d, J = 6.9 Hz), 7.99-7.88 (4 H, m), 7.61-7.30 (10 H, m), 6.68 (2 H, dd, J = 2.0, 8.4 Hz), 5.92 (1 H, dd, J = 7.5, 7.8 Hz), 5.77 (1 H, dd, J = 5.7, 7.8 Hz), 5.64 (1 H, d, J = 5.7 Hz), 5.49-5.40 (1 H, m), 4.53 (1 H, dd, J = 3.5, 13.2 Hz), 3.89 (1 H, dd, J = 8.0, 13.2 Hz), 2.62 (3 H, s); MS (ESI): 614 [M + NH₄ ⁺]. 18d: ¹H NMR (300 MHz, CDCl₃): δ = 12.97 (1 H, s), 8.06 (2 H, dd, J = 1.5, 8.4 Hz), 7.98 (2 H, dd, J = 1.5, 8.7 Hz), 7.91 (2 H, dd, J = 1.2, 8.4 Hz), 7.65-7.25 (10 H, m), 6.69 (1 H, d, J = 8.4 Hz), 6.67 (1 H, d, J = 8.4 Hz), 6.09 (1 H, dd, J = 6.6, 9.0 Hz), 5.81-5.75 (1 H, m), 5.71 (1 H, dd, J = 3.3, 9.0 Hz), 5.58 (1 H, d, J = 6.6 Hz), 4.43 (1 H, dd, J = 3.9, 13.2 Hz), 4.08 (1 H, dd, J = 2.0, 13.2 Hz), 2.66 (3 H, s); MS (ESI): 614 [M + NH₄ ⁺].